Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma

Summary: Tumor-infiltrating lymphocytes (TILs) are effective in the treatment of metastatic melanoma (MM), but toxicity limits its application. TILT-123 (igrelimogene litadenorepvec) is an oncolytic adenovirus producing interleukin-2 (IL-2) and tumor necrosis factor (TNF) upon replication. In this p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tine J. Monberg, Santeri A. Pakola, Benedetta Albieri, Eva Ellebaek, Marco Donia, Rikke L. Eefsen, Troels H. Borch, Tatiana V. Kudling, Torben Lorentzen, Helle W. Hendel, Cecilie Vestergaard, Cathrine Lorentzen, Rikke B. Holmstroem, Victor Arias, Amir Khammari, Claudia Kistler, João M. Santos, James H.A. Clubb, Lyna Haybout, Marie C.W. Westergaard, Özcan Met, Dafne C.A. Quixabeira, Elise Jirovec, Riikka Havunen, Suvi Sorsa, Victor Cervera-Carrascon, Brigitte Dreno, Akseli Hemminki, Inge Marie Svane
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2025-03-01
Colecção:	Cell Reports Medicine
Assuntos:	tumor-infiltrating lymphocytes TIL therapy oncolytic virus therapy cutaneous melanoma uveal melanoma mucosal melanoma
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666379125000898
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!